These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34901912)

  • 21. Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia.
    Warkentin TE; Greinacher A
    Thromb Res; 2021 Aug; 204():40-51. PubMed ID: 34144250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia.
    Lee CSM; Liang HPH; Connor DE; Dey A; Tohidi-Esfahani I; Campbell H; Whittaker S; Capraro D; Favaloro EJ; Donikian D; Kondo M; Hicks SM; Choi PY; Gardiner EE; Clarke LJ; Tran H; Passam FH; Brighton TA; Chen VM
    Blood Adv; 2022 Jun; 6(11):3494-3506. PubMed ID: 35359002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review and evolution of guidelines for diagnosis of COVID-19 vaccine induced thrombotic thrombocytopenia (VITT).
    Favaloro EJ; Pasalic L; Lippi G
    Clin Chem Lab Med; 2022 Jan; 60(1):7-17. PubMed ID: 34714985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine-induced immune thrombotic thrombocytopenia: Updates in pathobiology and diagnosis.
    Jevtic SD; Arnold DM; Modi D; Ivetic N; Bissola AL; Nazy I
    Front Cardiovasc Med; 2022; 9():1040196. PubMed ID: 36352844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential Anionic Substances Binding to Platelet Factor 4 in Vaccine-Induced Thrombotic Thrombocytopenia of ChAdOx1-S Vaccine for SARS-CoV-2.
    Pang X; Liu H; He X; Ji T; Zhu Y; Cui Y
    Front Immunol; 2021; 12():782335. PubMed ID: 35095856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complicated Long Term Vaccine Induced Thrombotic Immune Thrombocytopenia-A Case Report.
    Günther A; Brämer D; Pletz MW; Kamradt T; Baumgart S; Mayer TE; Baier M; Autsch A; Mawrin C; Schönborn L; Greinacher A; Thiele T
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
    Ostrowski SR; Søgaard OS; Tolstrup M; Stærke NB; Lundgren J; Østergaard L; Hvas AM
    Front Immunol; 2021; 12():779453. PubMed ID: 34887867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombosis with thrombocytopenia after the second ChAdOx1 nCoV-19 vaccination: A possible immunological mechanism independent of anti-platelet factor 4 antibody.
    Uaprasert N; Rojnuckarin P
    Asian Pac J Allergy Immunol; 2022 Mar; ():. PubMed ID: 35278060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European stroke organization interim expert opinion on cerebral venous thrombosis occurring after SARS-CoV-2 vaccination.
    Ferro JM; de Sousa DA; Coutinho JM; Martinelli I
    Eur Stroke J; 2021 Sep; 6(3):CXVI-CXXI. PubMed ID: 34746428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-PF4 VITT antibodies are oligoclonal and variably inhibited by heparin.
    Singh B; Kanack A; Bayas A; George G; Abou-Ismail MY; Kohlhagen M; Christ M; Naumann M; Moser K; Smock K; Grazioli A; Murray D; Padmanabhan A
    medRxiv; 2021 Sep; ():. PubMed ID: 34611669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT/TTS.
    Favaloro EJ; Pasalic L; Lippi G
    Antibodies (Basel); 2022 Jan; 11(1):. PubMed ID: 35225866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison.
    Sachs UJ; Cooper N; Czwalinna A; Müller J; Pötzsch B; Tiede A; Althaus K
    Thromb Haemost; 2021 Dec; 121(12):1622-1627. PubMed ID: 34169493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
    Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
    JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombosis with thrombocytopenia after AZD1222 (ChAdOx1 nCov-19) vaccination: Case characteristics and associations.
    Laffan MA; Rees S; Yadavalli M; Ferstenberg LB; Kumar Shankar N; Medin J; Foskett N; Arnold M; Gomes da Silva H; Bhuyan P; Nord M
    Vaccine; 2022 Sep; 40(38):5585-5593. PubMed ID: 35989136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais.
    Boonyawat K; Phojanasenee T; Noikongdee P; Police P; Chantrathammachart P; Niparuck P; Puavilai T; Phuphuakrat A; Angchaisuksiri P
    Thromb J; 2023 Sep; 21(1):92. PubMed ID: 37674185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral Venous Sinus Thrombosis due to Thrombosis with Thrombocytopenia Syndrome Following Ad26.COV2.S: A First Real-World Case Report of a Male Subject.
    Asif S; Kesireddy M; Koepsell SA; Gonzalez-Castellon MA; Gundabolu K; Baljevic M
    Neurohospitalist; 2022 Apr; 12(2):346-351. PubMed ID: 35419151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early recognition and treatment of pre-VITT syndrome after adenoviral vector-based SARS-CoV-2 vaccination may prevent from thrombotic complications: review of published cases and clinical pathway.
    Salih F; Kohler S; Schönborn L; Thiele T; Greinacher A; Endres M
    Eur Heart J Open; 2022 May; 2(3):oeac036. PubMed ID: 35919343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case Report of Cerebral Sinus Thrombosis Related to Immune Thrombotic Thrombocytopenia Following Administration of ChAdOx1 nCoV-19 for Vaccination against COVID-19.
    Szypowski W; Dębiec A; Świstak J; Nowocień M; Rzepecki P; Możański M; Staszewski J; Stępień A
    Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More.
    Lippi G; Favaloro EJ
    Semin Thromb Hemost; 2022 Feb; 48(1):8-14. PubMed ID: 34695859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.
    See I; Su JR; Lale A; Woo EJ; Guh AY; Shimabukuro TT; Streiff MB; Rao AK; Wheeler AP; Beavers SF; Durbin AP; Edwards K; Miller E; Harrington TA; Mba-Jonas A; Nair N; Nguyen DT; Talaat KR; Urrutia VC; Walker SC; Creech CB; Clark TA; DeStefano F; Broder KR
    JAMA; 2021 Jun; 325(24):2448-2456. PubMed ID: 33929487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.